CELL IDX, INC.
Multiplex immunohistochemistry (IHC) assays for quantitative breast cancer immunophenotyping using fluorescent detection panels
- Sector
- Medtech
- Headquarters
- SAN DIEGO, CA
- Latest Form D
- $775K, Sep 2020
- Total capital
- $3.3M
- Federal grants
- $2.5M
- 4 awards · 2015–2017
- Rank in peer group#92 of 112
- Private capital raised
- $775K
- 2 Form D · last Sep 2020
- 73 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 8 pending · first 2024
- Rank in peer group#34 of 112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$775K
- Offering registeredForm D · SEC · 1st filing$451K
- Federal grantHealth and Human S · Phase II · Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay$141K
- Federal grantHealth and Human S · Phase II · Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay$507K
- Federal grantHealth and Human S · Phase II · Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay$612K
- Federal grantHealth and Human S · Phase II · Development of a Multi Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
58months
from CELL IDX, INC.’s first federal award to its first private round.
- First federal award · Sep 2015
- Health and Human S · $1.3M
- First Form D · Aug 2020
- $451K · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 112 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
- Granted patents#34 · top 30%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- David SchwartzResearcherExecutive OfficerLinked by 1 patent · $2.5M in grants as PI
What it has protected
USPTO · 1 granted of 9- GrantedAntigen-coupled ImmunoreagentsUSPTOUS 11,867,696
- PendingMethods, Compositions, And Kits For Trapping Modified BiomoleculesUSPTOApplication 16815565
- PendingAntigen-coupled Hybridization ReagentsUSPTOApplication 16318801
Show all 9 patent records
- Antigen-coupled ImmunoreagentsJan 9, 2024 · US 11,867,696Granted
- Methods, Compositions, And Kits For Trapping Modified BiomoleculesFeb 4, 2021 · Application 16815565Pending
- Antigen-coupled Hybridization ReagentsAug 1, 2019 · Application 16318801Pending
- Antigen-coupled Hybridization ReagentsApplication 62363825Pending
- Antigen-coupled ImmunoreagentsApplication PCTUS2016016913Pending
- Antigen-coupled ImmunoreagentsApplication 62247415Pending
- Antigen-coupled ImmunoreagentsApplication 62113141Pending
- Methods, Compositions, And Kits For Trapping Modified BiomoleculesApplication 62816797Pending
- Antigen-coupled Hybridization ReagentsApplication PCTUS2017042659Pending
Related companies, and why
- SCION NEUROSTIM, LLCSimilar federal contract value in Medtech · null in contracts
- CONTRALINE, INC.Similar federal contract value in Medtech · null in contracts
- FAUXSEE INNOVATIONS LLCSimilar federal contract value in Medtech · null in contracts
- PROTEAS BIOANALYTICS INC.Similar federal contract value in Medtech · null in contracts
- GATEWAY BIOTECHNOLOGY, INC.Similar federal contract value in Medtech · null in contracts
- MicroStructure Imaging, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .